BioXcel Therapeutics, Inc. (BTAI)
NASDAQ · Healthcare
BioXcel Therapeutics, Inc. PS Ratio 2018–2026
Current and historical P/S ratio for BioXcel Therapeutics, Inc. (BTAI): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 53.35.
From: 03/31/2018To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
BioXcel Therapeutics, Inc. PS Ratio — FAQ
BioXcel Therapeutics, Inc. (BTAI) ps ratio over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTAI's ps ratio history?
The chart and table above show BioXcel Therapeutics, Inc.'s ps ratio by year and by quarter, including the growth rate.